New search | Conferencedetail
mail
Print view
 
 

ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit

Evvnt Promotion / evvnt
Archive
-
09.09.2024 - 10.09.2024  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Conference themes
Major moves in the pharma and biotech partnering are reshaping the landscape. With AbbVie's acquisition of ImmunoGen leading the charge in 2023, and Merck's licensing deal with Daiichi reaching unprecedented heights across three ADC programs, the market frenzy surrounding ADCs has never been hotter.

Even Eli Lilly's acquisition of Mablink, despite lacking clinical programs, underscores the feverish pace of activity in the field, breaking traditional pharma partnering trends.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2481194-3?pid=4832

Speakers: Adrianne Wong, Director, Oncology Search and Evaluation, Global Business Development, Daiichi Sankyo, Albert Hsia, Executive Director, Business Development, Merck, and more
 

Enquiries and Registration:

https://go.evvnt.com/2481194-2?pid=4832
Ms. Karina Bikerniece
 
Categories
General Medicine
Languages
English
Congress fees
Two Day Attendance and Access to Partnering Portal - Biotech, Pharma and Investors: USD 2999.00, Two Day Attendance and Access to Partnering Portal - Academics: USD 2399.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationÄrztekammer für WienÄrzte der WeltEuropean Public Health Association (EUPHA)Hilfswerk AustriaSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.European Health Forum Gastein